Multiparameteric PET-MR Assessment of Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer: PET, MR, PET-MR and Tumor Texture Analysis: A Pilot Study
- 1 Joint Department of Medical Imaging, University Health Network, Mount Sinai Hospital and Women’s College Hospital, University of Toronto, Toronto, Canada
- 2 Joint Department of Medical Imaging, University Health Network, Mount Sinai Hospital and Women’s College Hospital, University of Toronto, Toronto, Canada
- 3 Joint Department of Medical Imaging, University Health Network, Mount Sinai Hospital and Women’s College Hospital, University of Toronto, Toronto, Canada
- 4 Joint Department of Medical Imaging, University Health Network, Mount Sinai Hospital and Women’s College Hospital, University of Toronto, Toronto, Canada
- 5 Joint Department of Medical Imaging, University Health Network, Mount Sinai Hospital and Women’s College Hospital, University of Toronto, Toronto, Canada
- 6 Joint Department of Medical Imaging, University Health Network, Mount Sinai Hospital and Women’s College Hospital, University of Toronto, Toronto, Canada
- 7 Division of General Surgery, University Health Network & Mount Sinai Hospital, University of Toronto, Toronto, Canada
Abstract
Purpose: Patients with locally advanced rectal cancer (LARC) achieving pathologic complete response (pCR) to neoadjuvant chemoradiotherapy (CRT) have significantly improved long term survival. Preoperative detection of pCR may enable a conservative therapeutic approach in some patients. The purpose of the current prospective pilot study was to assess multiparametric qualitative and quantitative MR, PET, PET-MR and tumor texture features in predicting pCR to CRT in patients with LARC. Material and Methods: Eighteen LARC patients underwent staging with FDG-PET and MR-rectum and 15 had post-CRT restaging. Response was assessed qualitatively and quantitatively. SUV (tumor/background), SUV/ADC, and tumor texture parameters derived via machine learning algorithms (MLA) from PET and multiple MR sequences and were correlated with histopathology. Results: A third of patients had pCR. Sensitivity, specificity & accuracy of PET, MR and combined PET-MR were 90, 60, & 80; 90, 20 & 66.7; 90, 80 & 86.7, respectively. Differences did not reach statistical significance. Quantitatively, only tumor-muscle (SUV/ADC) ratio improved prediction of pCR. Of all texture features assessed using MLA, only the classifier trained on pre-treatment PET was significant (p = 0.034; accuracy, 92.8%). Combined PET and MR texture features did not improve performance. Conclusion: Combined PET-MR may improve specificity compared with PET or MR alone, although this needs to be validated in a larger cohort. Tumor to muscle SUV/ADC ratios post-therapy and texture features on baseline PET show promise in improving prediction of pCR post-CRT in LARC.
- Maas, M., Nelemans, P.J., Valentini, V., Das, P., Rödel, C., Kuo, L.J., et al. (2010) Long-Term Outcome in Patients with a Pathological Complete Response after Chemoradiation for Rectal Cancer: A Pooled Analysis of Individual Patient Data. Lancet Oncology, 11, 835-844. http://dx.doi.org/10.1016/S1470-2045(10)70172-8
- Zorcolo, L., Rosman, A.S., Restivo, A., Pisano, M., Nigri, G.R., Fancellu, A., et al. (2012) Complete Pathologic Response after Combined Modality Treatment for Rectal Cancer and Long-Term Survival: A Meta-Analysis. Annals of Surgical Oncology, 19, 2822-2832. http://dx.doi.org/10.1245/s10434-011-2209-y
- Martin, S.T., Heneghan, H.M. and Winter, D.C. (2012) Systematic Review and Meta-Analysis of Outcomes Following Pathological Complete Response to Neoadjuvant Chemoradiotherapy for Rectal Cancer. British Journal of Surgery, 99, 918-928. http://dx.doi.org/10.1002/bjs.8702
- Habr-Gama, A., Perez, R., Proscurshim, I. and Gama-Rodrigues, J. (2010) Complete Clinical Response after Neoadjuvant Chemoradiation for Distal Rectal Cancer. Surgical Oncology Clinics of North America, 19, 829-845. http://dx.doi.org/10.1016/j.soc.2010.08.001
- Maas, M., Beets-Tan, R.G.H., Lambregts, D.M., Lammering, G., Nelemans, P.J., Engelen, S.M., et al. (2011) Wait-and-See Policy for Clinical Complete Responders after Chemoradiation for Rectal Cancer. Journal of Clinical Oncology, 29, 4633-4640. http://dx.doi.org/10.1200/JCO.2011.37.7176
- Patel, U.B., Blomqvist, L.K., Taylor, F., George, C., Gurthrie, A., Bees, N., et al. (2012) MRI after Treatment of Locally Advanced Rectal Cancer: How to Report Tumor Response—The MERCURY Experience. American Journal of Roentgenology, 199, W486-W495. http://dx.doi.org/10.2214/ajr.11.8210
- Patel, U.B., Taylor, F., Blomqvist, L., George, C., Evans, H., Tekkis, P., et al. (2011) Magnetic Resonance Imaging-Detected Tumor Response for Locally Advanced Rectal Cancer Predicts Survival Outcomes: MERCURY Experience. Journal of Clinical Oncology, 29, 3753-3760. http://dx.doi.org/10.1200/JCO.2011.34.9068
- Mandard, A., Dalibard, F., Mandard, J., Marnay, J., Henry-Amar, M., Petiot, J.F., et al. (1994) Pathologic Assessment of Tumor Regression after Preoperative Chemoradiotherapy of Esophageal Carcinoma. Clinicopathologic Correlations. Cancer, 73, 2680-2686. http://dx.doi.org/10.1002/1097-0142(19940601)73:11 3.0.CO;2-C
- Ryan, R., Gibbons, D., Hyland, J.M., Treanor, D., White, A., Mulcahy, H.E., et al. (2005) Pathological Response Following Long-Course Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. Histopathology, 47, 141-146. http://dx.doi.org/10.1111/j.1365-2559.2005.02176.x